Trump Contemplates Reclassification of Marijuana
In a surprising turn of events, President Trump is reportedly mulling over the idea of reclassifying marijuana as a less dangerous substance. This potential shift may signal a significant change in the legal landscape of cannabis in the United States.
A recent report from The Wall Street Journal reveals that during a New Jersey fundraiser, Trump expressed interest in pursuing this reclassification. The Biden administration had initiated steps toward this very change, but the transition stalled before any concrete action could be taken. A reclassification could not only simplify the buying and selling processes for marijuana but could also significantly enhance profitability in the burgeoning multibillion-dollar cannabis industry.
At the fundraiser, among notable attendees was Kim Rivers, CEO of Trulieve, a leading cannabis company. Rivers is said to have passionately advocated for Trump to support the reclassification and to broaden the scope of medical marijuana research. Other influential figures present included the CEO of Pfizer, cryptocurrency leaders, and various political advisors close to Trump. The discussions extended into the realm of New York politics and included dialogues with additional donors.
TRUMP EYES MARIJUANA RECLASSIFICATION AFTER MILLION DOLLAR DINNER
Cannabis executives finally got Trump’s ear at a New Jersey fundraiser.
Their pitch? Finish what Biden started but couldn’t deliver on marijuana reclassification.
Trulieve CEO Kim Rivers made the case… https://t.co/05xRoZQS0d pic.twitter.com/2ifKGXH0ZZ
— Mario Nawfal (@MarioNawfal) August 9, 2025
The Current Debate
The prevailing discussion revolves around whether marijuana should be moved to Schedule III. While this wouldn’t legalize it outright, it would certainly ease restrictions. Such a change could pave the way for tax deductions for certain cannabis enterprises and broaden the horizons for medical research.
Last September, Trump publicly endorsed a legalization measure in Florida, which Governor Ron DeSantis opposed. Interestingly, this initiative failed to meet the necessary 60 percent threshold for passage.
Trump Clarifies his Policy in Marijuana…
He’s ok with it, as long as…
• you got to be a certain age to buy it
• it’s done in a safe and lawful way
• he emphasizes the way they’re doing in Florida might be the way to goI sense he’s not for it, but it’s such a popular… pic.twitter.com/vWDUAXXbKb
— MJTruthUltra (@MJTruthUltra) September 3, 2024
Concerns and Criticisms
While Trump has voiced a commitment to prioritizing research into the medicinal benefits of marijuana and addressing other policy objectives favored by the cannabis sector, critics remain skeptical. They argue that downgrading cannabis could misrepresent its risks, particularly its established links to severe mental health issues such as psychosis and schizophrenia, especially among vulnerable populations. Furthermore, opponents caution that increased access could potentially elevate addiction rates and exacerbate the existing strain on public health systems already coping with substance-related challenges.
A spokesperson for the White House stated that no final decision has yet been made and that discussions are still in progress. “All policy and legal requirements and implications are being considered,” said Abigail Jackson, emphasizing that the guiding principle behind the president’s policy decisions is the best interest of the American people.
